Literature DB >> 422662

Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro.

R F Diegelmann, I K Cohen, B J McCoy.   

Abstract

Fibroblasts were isolated from keloid, normal skin, and normal scar and maintained in tissue culture for four passages. Growth kinetics were the same for all groups on days 2 through 12. However, the rate of collagen synthesis per fibroblast was greater in keloid derived cells than any controls at all growth phases. Keloid fibroblasts have an autonomous capacity to synthesize collagen at a significantly increased level in vitro, which may explain in part why these lesions are characterized by increased collagen deposition.

Mesh:

Substances:

Year:  1979        PMID: 422662     DOI: 10.1002/jcp.1040980210

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  21 in total

1.  Cellular senescence as a possible mechanism for halting progression of keloid lesions.

Authors:  Shohreh Varmeh; Ainara Egia; Duncan McGrouther; Steven R Tahan; Ardeshir Bayat; Pier Paolo Pandolfi
Journal:  Genes Cancer       Date:  2011-11

Review 2.  Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring.

Authors:  Peter Adam Rees; Nicholas Stuart Greaves; Mohamed Baguneid; Ardeshir Bayat
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

Review 3.  Aetiology and management of hypertrophic scars and keloids.

Authors:  S T O'Sullivan; M O'Shaughnessy; T P O'Connor
Journal:  Ann R Coll Surg Engl       Date:  1996-05       Impact factor: 1.891

4.  Altered steady-state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts.

Authors:  J Uitto; A J Perejda; R P Abergel; M L Chu; F Ramirez
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

5.  Distinctive fibroblastic subpopulations in skin and oral mucosa demonstrated by differences in glycosaminoglycan content.

Authors:  R E Bronson; J G Argenta; E P Siebert; C N Bertolami
Journal:  In Vitro Cell Dev Biol       Date:  1988-11

Review 6.  Extracellular matrix as a driver of progressive fibrosis.

Authors:  Jeremy Herrera; Craig A Henke; Peter B Bitterman
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

7.  CD44 and hyaluronan expression in human cutaneous scar fibroblasts.

Authors:  D V Messadi; C N Bertolami
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

8.  Type 1 procollagen as a marker of severity of scarring after sternotomy: effects of topical corticosteroids.

Authors:  Y Riaz; H T Cook; A Wangoo; B Glenville; R J Shaw
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

9.  Role of Hyaluronic Acid Treatment in the Prevention of Keloid Scarring.

Authors:  Andrea Hoffmann; Jessica Lynn Hoing; Mackenzie Newman; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2013-07-01

10.  Characterization of human vocal fold fibroblasts derived from chronic scar.

Authors:  Marie E Jetté; Supriya D Hayer; Susan L Thibeault
Journal:  Laryngoscope       Date:  2013-03       Impact factor: 3.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.